|
1
|
Ding Z, Liang J, Lu Y, Yu Q, Songyang Z,
Lin SY and Mills GB: A retrovirus-based protein complementation
assay screen reveals functional AKT1-binding partners. Proc Natl
Acad Sci USA. 103:15014–15019. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peng M, Yang M, Ding Y, Yu L, Deng Y, Lai
W and Hu Y: Mechanism of endogenous digitalis-like factorinduced
vascular endothelial cell damage in patients with severe
preeclampsia. Int J Mol Med. 41:985–994. 2018.PubMed/NCBI
|
|
3
|
Varberg KM and Soares MJ: Paradigms for
investigating invasive trophoblast cell development and
contributions to uterine spiral artery remodeling. Placenta. May
3–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miko E, Meggyes M, Bogar B, Schmitz N,
Barakonyi A, Varnagy A, Farkas B, Tamas P, Bodis J, Szekeres-Bartho
J, et al: Involvement of Galectin-9/TIM-3 pathway in the systemic
inflammatory response in early-onset preeclampsia. PLoS One.
8:e718112013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anim-Nyame N, Gamble J, Sooranna SR,
Johnson MR and Steer PJ: Relationship between insulin resistance
and tissue blood flow in preeclampsia. J Hypertens. 33:1057–1063.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Knofler M and Pollheimer J: IFPA award in
placentology lecture: Molecular regulation of human trophoblast
invasion. Placenta. 33 (Suppl 2):S55–S62. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burke SD, Zsengeller ZK, Khankin EV, Lo
AS, Rajakumar A, DuPont JJ, McCurley A, Moss ME, Zhang D, Clark CD,
et al: Soluble fms-like tyrosine kinase 1 promotes angiotensin II
sensitivity in preeclampsia. J Clin Invest. 126:2561–2574. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Merviel P, Carbillon L, Challier JC,
Rabreau M, Beaufils M and Uzan S: Pathophysiology of preeclampsia:
Links with implantation disorders. Eur J Obstet Gynecol Reprod
Biol. 115:134–147. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hong K, Park HJ and Cha D: Clinical
implications of placenta-derived angiogenic/anti-angiogenic
biomarkers in pre-eclampsia. Biomark Med. 15:523–536. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grisaru-Granovsky S, Maoz M, Barzilay O,
Yin YJ, Prus D and Bar-Shavit R: Protease activated receptor-1,
PAR1, promotes placenta trophoblast invasion and beta-catenin
stabilization. J Cell Physiol. 218:512–521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vaiman D: Genes, epigenetics and miRNA
regulation in the placenta. Placenta. 52:127–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morales-Prieto DM, Ospina-Prieto S,
Chaiwangyen W, Schoenleben M and Markert UR: Pregnancy-associated
miRNA-clusters. J Reprod Immunol. 97:51–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jairajpuri DS, Malalla ZH, Mahmood N and
Almawi WY: Circulating microRNA expression as predictor of
preeclampsia and its severity. Gene. 627:543–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding J, Huang F, Wu G, Han T, Xu F, Weng
D, Wu C, Zhang X, Yao Y and Zhu X: MiR-519d-3p suppresses invasion
and migration of trophoblast cells via targeting MMP-2. PLoS One.
10:e01203212015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xueya Z, Yamei L, Sha C, Dan C, Hong S,
Xingyu Y and Weiwei C: Exosomal encapsulation of miR-125a-5p
inhibited trophoblast cell migration and proliferation by
regulating the expression of VEGFA in preeclampsia. Biochem Biophys
Res Commun. 525:646–653. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brooks SA, Martin E, Smeester L, Grace MR,
Boggess K and Fry RC: miRNAs as common regulators of the
transforming growth factor (TGF)-β pathway in the preeclamptic
placenta and cadmium-treated trophoblasts: Links between the
environment, the epigenome and preeclampsia. Food Chem Toxicol.
98:50–57. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang X and Meng T: miR-215-5p decreases
migration and invasion of trophoblast cells through regulating CDC6
in preeclampsia. Cell Biochem Funct. 38:472–479. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tamaru S, Mizuno Y, Tochigi H, Kajihara T,
Okazaki Y, Okagaki R, Kamei Y, Ishihara O and Itakura A:
MicroRNA-135b suppresses extravillous trophoblast-derived
HTR-8/SVneo cell invasion by directly down regulating CXCL12 under
low oxygen conditions. Biochem Biophys Res Commun. 461:421–426.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pankiewicz K, Fijalkowska A, Issat T and
Maciejewski TM: Insight into the key points of preeclampsia
pathophysiology: Uterine artery remodeling and the role of
microRNAs. Int J Mol Sci. 22:31322021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lv Y, Lu C, Ji X, Miao Z, Long W, Ding H
and Lv M: Roles of microRNAs in preeclampsia. J Cell Physiol.
234:1052–1061. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen J, Zhao L, Wang D, Xu Y, Gao H, Tan W
and Wang C: Contribution of regulatory T cells to immune tolerance
and association of microRNA210 and Foxp3 in preeclampsia. Mol Med
Rep. 19:1150–1158. 2019.PubMed/NCBI
|
|
22
|
Ahmadalizadeh Khanehsar M, Hoseinbeyki M,
Fakhr Taha M and Javeri A: Repression of TGF-β signaling in breast
cancer cells by miR-302/367 cluster. Cell J. 21:444–450.
2020.PubMed/NCBI
|
|
23
|
Yang CM, Chiba T, Brill B, Delis N, von
Manstein V, Vafaizadeh V, Oellerich T and Groner B: Expression of
the miR-302/367 cluster in glioblastoma cells suppresses
tumorigenic gene expression patterns and abolishes transformation
related phenotypes. Int J Cancer. 137:2296–2309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang Y, Hou R, Li S, Li S and Dang G:
MicroRNA-302 inhibits cell migration and invasion in cervical
cancer by targeting DCUN1D1. Exp Ther Med. 16:1000–1008.
2018.PubMed/NCBI
|
|
25
|
Kim JY, Shin KK, Lee AL, Kim YS, Park HJ,
Park YK, Bae YC and Jung JS: MicroRNA-302 induces proliferation and
inhibits oxidant-induced cell death in human adipose tissue-derived
mesenchymal stem cells. Cell Death Dis. 5:e13852014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo Y, Cui J, Ji Z, Cheng C, Zhang K,
Zhang C, Chu M, Zhao Q, Yu Z, Zhang Y, et al: miR-302/367/LATS2/YAP
pathway is essential for prostate tumor-propagating cells and
promotes the development of castration resistance. Oncogene.
36:6336–6347. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng L, Sharples RA, Scicluna BJ and Hill
AF: Exosomes provide a protective and enriched source of miRNA for
biomarker profiling compared to intracellular and cell-free blood.
J Extracell Vesicles. 32014.doi: 10.3402/jev.v3.23743. PubMed/NCBI
|
|
28
|
Melo SA, Sugimoto H, O'connell JT, Kato N,
Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et
al: Cancer exosomes perform cell-independent microRNA biogenesis
and promote tumorigenesis. Cancer Cell. 26:707–721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thery C, Amigorena S, Raposo G and Clayton
A: Isolation and characterization of exosomes from cell culture
supernatants and biological fluids. Curr Protoc Cell Biol.
3:222006.PubMed/NCBI
|
|
31
|
Zhu Q, Li Q, Niu X, Zhang G, Ling X, Zhang
J, Wang Y and Deng Z: Extracellular vesicles secreted by human
urine-derived stem cells promote ischemia repair in a mouse model
of hind-limb ischemia. Cell Physiol Biochem. 47:1181–1192. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu F, Wu W, Wu K, Chen Y, Wu H, Wang H
and Zhang W: MiR-203 participates in human placental angiogenesis
by inhibiting VEGFA and VEGFR2 expression. Reprod Sci. 25:358–365.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rada CC, Murray G and England SK: The SK3
channel promotes placental vascularization by enhancing secretion
of angiogenic factors. Am J Physiol Endocrinol Metab.
307:E935–E943. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moser G, Guettler J, Forstner D and
Gauster M: Maternal platelets-friend or foe of the human placenta?
Int J Mol Sci. 20:56392019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pereira RD, De Long NE, Wang RC, Yazdi FT,
Holloway AC and Raha S: Angiogenesis in the placenta: The role of
reactive oxygen species signaling. Biomed Res Int. 2015:8145432015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reynolds LP and Redmer DA: Angiogenesis in
the placenta. Biol Reprod. 64:1033–1040. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bogic LV, Brace RA and Cheung CY:
Developmental expression of vascular endothelial growth factor
(VEGF) receptors and VEGF binding in ovine placenta and fetal
membranes. Placenta. 22:265–275. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Devi HL, Kumar S, Konyak YY, Bharati J,
Bhimte A, Pandey Y, Kumar K, Paul A, Kala A, Samad HA, et al:
Expression and functional role of fibroblast growth factors (FGF)
in placenta during different stages of pregnancy in water buffalo
(Bubalus bubalis). Theriogenology. 143:98–112. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tian KW, Zhang YY, Jiang H and Han S:
Author correction: Intravenous C16 and angiopoietin-1 improve the
efficacy of placenta-derived mesenchymal stem cell therapy for EAE.
Sci Rep. 10:80972020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ferrara N, Gerber HP and Lecouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jussila L and Alitalo K: Vascular growth
factors and lymphangiogenesis. Physiol Rev. 82:673–700. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
George J, Shmilovich H, Deutsch V, Miller
H, Keren G and Roth A: Comparative analysis of methods for
assessment of circulating endothelial progenitor cells. Tissue Eng.
12:331–335. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nagineni CN, William A, Cherukuri A,
Samuel W, Hooks JJ and Detrick B: Inflammatory cytokines regulate
secretion of VEGF and chemokines by human conjunctival fibroblasts:
Role in dysfunctional tear syndrome. Cytokine. 78:16–19. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Holmes DI and Zachary I: The vascular
endothelial growth factor (VEGF) family: Angiogenic factors in
health and disease. Genome Biol. 6:2092005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ferrara N: Vascular endothelial growth
factor: Basic science and clinical progress. Endocr Rev.
25:581–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
An H J, Kim JH, Ahn EH, Kim YR, Kim JO,
Park HS, Ryu CS, Kim EG, Cho SH, Lee WS and Kim NK: 3′-UTR
polymorphisms in the vascular endothelial growth factor gene (VEGF)
contribute to susceptibility to recurrent pregnancy loss (RPL). Int
J Mol Sci. 20:33192019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Coultas L, Chawengsaksophak K and Rossant
J: Endothelial cells and VEGF in vascular development. Nature.
438:937–945. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nevo O, Lee DK and Caniggia I: Attenuation
of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta.
PLoS One. 8:e811762013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang K, Jiang YZ, Chen DB and Zheng J:
Hypoxia enhances FGF2- and VEGF-stimulated human placental artery
endothelial cell proliferation: Roles of MEK1/2/ERK1/2 and
PI3K/AKT1 pathways. Placenta. 30:1045–1051. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Song C, Xie S, Wang J, Lian J, Diao B and
Tang Y: Association of angiotensinogen gene polymorphisms and
angiogenic factors with preeclampsia in Chinese women. Gynecol
Obstet Invest. 76:64–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang Z, Hong Y, Xiang D, Zhu P, Wu E, Li
W, Mosenson J and Wu WS: MicroRNA-302/367 cluster governs hESC
self-renewal by dually regulating cell cycle and apoptosis
pathways. Stem Cell Rep. 4:645–657. 2015. View Article : Google Scholar
|
|
52
|
Liu FY, Wang LP, Wang Q, Han P, Zhuang WP,
Li MJ and Yuan H: miR-302b regulates cell cycles by targeting CDK2
via ERK signaling pathway in gastric cancer. Cancer Med.
5:2302–2313. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Thery C, Zitvogel L and Amigorena S:
Exosomes: Composition, biogenesis and function. Nat Rev Immunol.
2:569–579. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
54
|
Monaco F, Gaetani S, Alessandrini F,
Tagliabracci A, Bracci M, Valentino M, Neuzil J, Amati M, Bovenzi
M, Tomasetti M and Santarelli L: Exosomal transfer of miR-126
promotes the anti-tumour response in malignant mesothelioma: Role
of miR-126 in cancer-stroma communication. Cancer Lett. 463:27–36.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liu X, Lu Y, Xu Y, Hou S, Huang J, Wang B,
Zhao J, Xia S, Fan S, Yu X, et al: Exosomal transfer of miR-501
confers doxorubicin resistance and tumorigenesis via targeting of
BLID in gastric cancer. Cancer Lett. 459:122–134. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li H, Ouyang Y, Sadovsky E, Parks WT, Chu
T and Sadovsky Y: Unique microRNA signals in plasma exosomes from
pregnancies complicated by preeclampsia. Hypertension. 75:762–771.
2020. View Article : Google Scholar : PubMed/NCBI
|
